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Abstract
Purpose Cardiac PET-MR has shown potential for the comprehensive assessment of coronary heart disease. However, image
degradation due to physiological motion remains a challenge that could hinder the adoption of this technology in clinical practice.
The purpose of this study was to validate a recently proposed respiratory motion-corrected PET-MR framework for the simul-
taneous visualisation of myocardial viability (18F-FDG PET) and coronary artery anatomy (coronary MR angiography, CMRA)
in patients with chronic total occlusion (CTO).
Methods A cohort of 14 patients was scanned with the proposed PET-CMRA framework. PET and CMRA images were
reconstructed with and without the proposed motion correction approach for comparison purposes. Metrics of image quality
including visible vessel length and sharpness were obtained for CMRA for both the right and left anterior descending coronary
arteries (RCA, LAD), and relative increase in 18F-FDG PET signal after motion correction for standard 17-segment polar maps
was computed. Resulting coronary anatomy by CMRA and myocardial integrity by PETwere visually compared against X-ray
angiography and conventional Late Gadolinium Enhancement (LGE) MRI, respectively.
Results Motion correction increased CMRA visible vessel length by 49.9% and 32.6% (RCA, LAD) and vessel sharpness by
12.3% and 18.9% (RCA, LAD) on average compared to uncorrected images. Coronary lumen delineation on motion-corrected
CMRA images was in good agreement with X-ray angiography findings. For PET, motion correction resulted in an average 8%
increase in 18F-FDG signal in the inferior and inferolateral segments of the myocardial wall. An improved delineation of
myocardial viability defects and reduced noise in the 18F-FDG PET images was observed, improving correspondence to suben-
docardial LGE-MRI findings compared to uncorrected images.
Conclusion The feasibility of the PET-CMRA framework for simultaneous cardiac PET-MR imaging in a short and predictable
scan time (~11 min) has been demonstrated in 14 patients with CTO.Motion correction increased visible length and sharpness of
the coronary arteries by CMRA, and improved delineation of the myocardium by 18F-FDG PET, resulting in good agreement
with X-ray angiography and LGE-MRI.
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Introduction
Simultaneous PET-MR imaging has shown promising results
for the comprehensive assessment of several cardiac condi-
tions in initial clinical studies [1–5]. Dweck et al. [6] observed
increased accuracy for the diagnosis of active cardiac sarcoid-
osis by combining 18F-fluorodeoxyglucose (18F-FDG) PET
and cardiovascularMR (CMR). Nensa et al. [7] showed prom-
ising results of increased sensitivity for the detection of bor-
derline myocarditis using hybrid 18F-FDG PET and CMR
scans. A significant PET-MR intermodality agreement was
observed in acute myocardial infarction [8], and more recently
CMR in combination with 18F-FDG and 18F-sodium fluoride
(18F-NaF) was successfully used for imaging of inflammation
and calcification in the coronary arteries [9].
Most of the currently used cardiac PET-MR imaging
workflows consist of the acquisition of several MR images with
differing contrasts, while simultaneously acquiring list-mode
PET data throughout the whole or most of the scanning session.
Cardiac MR images acquired in these protocols typically in-
clude a stack of cine images, Late Gadolinium Enhancement
(LGE), coronary MR angiography (CMRA) and T1 and T2
mapping, leading to scanning sessions that range between 30
and 90 min in duration [6, 8, 9]. During this prolonged exam-
ination time, physiological motion occurs due to breathing and
cardiac motion (contraction and relaxation), thus requiring mo-
tion compensation techniques to minimise ghosting, blurring
and associated image artefacts in both modalities.
Cardiac motion compensation is typically achieved in MR
by synchronising the acquisition with an external electrocar-
diogram (ECG) device and acquiring data only during the
quiescent periods of the cardiac cycle, e.g. mid-diastole.
Respiratory motion is conventionally addressed in a similar
fashion, by acquiring and accepting data only during a specific
respiratory phase of minimal motion, typically end-expiration.
Surrogate signals that have a strong correlation with the respi-
ratory motion of the heart are used for synchronisation, either
from external devices (such as respiratory bellows) or image-
derived signals (such as monitoring the position of the lung-
liver interface, so-called 1D image navigators) [10]. These
approaches, however, lead to long and unpredictable scan
times due to breathing pattern variations and drifting.
Similar approaches have been proposed for cardiac PET im-
aging [11], so that the acquired list-mode data are dual-gated
into a number of cardiac and respiratory phases, and only data
acquired during end-expiration and mid-diastole are used for
image reconstruction. However, the significant reduction in
data available in each gate produces images with increased
noise. Therefore, in practice, most of the clinical studies still
aggregate all the acquired data into a single static time frame
blurred by both respiratory and cardiac motion [6, 8].
Simultaneous PET-MR technology has shown potential for
addressing the motion problem in PET by incorporating
motion information estimated from simultaneously acquired
MR images into PET image reconstruction. In order to obtain
motion information, a set of MR images is acquired at differ-
ent cardiac and respiratory positions, and motion is estimated
by non-rigid registration of the images for each frame, typi-
cally using the end-diastolic and end-expiration frame as ref-
erence [12]. The simultaneously acquired PET data is then
sorted into corresponding frames, and MR-based motion
fields are incorporated into the PET image reconstruction
[13, 14] to reduce motion induced blurring and artefacts, im-
proving PET image quality and quantification [12].
In most of the current approaches for MR-based motion
correction of cardiac PET data, the MR images acquired si-
multaneously with PET are designed for motion estimation
purposes only [15–17]. The lack of appropriate tissue contrast
and/or sufficient spatial resolution of these MR images might
prevent their use for diagnostic purposes. This may lead to
prolonged examination times, since diagnostic MR images
are to be acquired after the simultaneous PET-MR
examination.
We have recently proposed a different approach for the
acquisition of motion-corrected cardiac PET-MR images
[18]. With this approach motion estimated from MR images
is used to correct both 18F-FDG PET and CMRA datasets,
enabling visualisation of myocardial viability and coronary
anatomy in a single efficient examination. This PET-CMRA
motion correction framework is based on 2D image-based
navigation [19, 20], thus allowing for 100% scan efficiency
(no respiratory gating window with concomitant data rejec-
tion) and predictable scan time. The feasibility of this PET-
CMRA framework was shown in a small cohort (N = 5) of
oncology patients without known or suspected coronary artery
disease (CAD) [18], however its feasibility in patients with
cardiovascular disease has not been investigated yet. Here
we present an initial clinical validation of this method for the
simultaneous visualisation of myocardial integrity by 18F-
FDG PETand coronary lumen integrity by CMRA. The study
was performed in a cohort of patients with known CAD, in
particular, patients with chronic total occlusion of at least one
of the coronary arteries.
Materials and methods
PET-MR image acquisition
The whole-heart PET-CMRA acquisition consists of a free-
breathing ECG-triggered CMRA sequence simultaneously ac-
quired with list-mode cardiac PET data (Fig. 1a) as proposed
in [18]. CMRA data is acquired using a 3D spoiled gradient
echo sequence following a fully sampled golden-step
Cartesian trajectory with spiral profile ordering [21], so that
one spiral interleaf is acquired at each heartbeat. A low-
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Fig. 1 PET-CMRA acquisition and reconstruction scheme. a PET-
CMRA acquisition sequence, an image-navigator (2D iNAV) is
acquired at each heartbeat before the CMRA acquisition for estimating
respiratory motion. T2prep and FatSat preparation pulses are performed
to improve contrast between blood and surrounding tissue. b
Translational motion in FH and RL directions is estimated from the 2D
iNAVs by rigid registration of a template covering the apex of the heart (in
red). c FH motion is used to bin the PET and CMRA data in a number of
respiratory windows. FH and RL motion is used to correct the CMRA
data to the centre of each bin (green arrows). d Non-rigid deformation
fields are estimated from MR images reconstructed at each respiratory
position and e used to move the attenuation maps to each respiratory
position, and in motion compensated PET and CMRA image
reconstruction
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resolution coronal 2D image navigator (iNAV) [19] for respi-
ratory motion estimation is acquired at the beginning of each
interleaf by spatially encoding low flip angle k-space lines. Fat
saturation (Fat Sat) and T2-preparation (T2-prep) [22] pulses
are performed immediately prior to data acquisition to im-
prove the contrast between arterial blood and the surrounding
myocardium and epicardial fat.
As part of the cardiac PET-CMRA acquisition protocol, a
standard Dixon-based attenuation map (μ-map) is acquired in
breath-hold at end-expiration for MR-based attenuation cor-
rection of the PET data [23], with missing tissue due to the
limited field of view of the MR (as compared to PET) estimat-
ed using the MLAA (Maximum Likelihood reconstruction of
Attenuation and Activity) approach [24]. Additionally, a con-
ventional 2D cine image is acquired for defining the trigger
delay and length of the acquisition window of the 3D CMRA.
PET-MR image reconstruction
Motion compensated image reconstruction is performed in four
steps (Fig. 1b-e). In the first step, foot-head (FH) and right-left
(RL) translational respiratory motion is estimated from the 2D
iNAVs by using rigid image registration of a template covering
the apex of the heart (Fig. 1b). This allows measuring directly
the respiratory-induced translational motion of the heart in a
beat-to-beat fashion. In the second step, FH motion is used to
bin the acquired PET and CMRA data in a number of respira-
tory windows ranging from end-expiration to end-inspiration,
each containing the same amount of data (Fig. 1c). Outlier
rejection is performed in this step, by excluding CMRA data
acquired in deep breaths [18]. CMRAdata acquired within each
respiratory window is then corrected to the centre of the bin by
applying a phase shift in k-space according to the estimated FH
and RL motion. In a third step, 3D MR images are reconstruct-
ed at each respiratory position using iterative SENSE with a
soft-binning approach [18, 20], and bin-to-bin respiratory de-
formation fields are estimated by non-rigid image registration,
using the end-expiration bin as reference (Fig. 1d). Finally, the
non-rigid deformation fields are used in a generalised matrix
description formulation for motion-compensated CMRA re-
construction [25]. Moreover, the non-rigid motion fields are
also used to move the attenuation maps to each respiratory
position (Fig. 1e) and perform a motion-compensated PET re-
construction. Therefore, at the end of the reconstruction pro-
cess, co-registered respiratory motion-corrected CMRA and
cardiac PET images are obtained.
Experiments
Fourteen patients with symptomatic CAD (angina or angina
equivalent, excluding acute STEMI patients), chronic total
occlusion (CTO) of a relevant coronary artery (segment 1, 2,
6, 7, 11 or 13, diameter > 2.5 mm), and echocardiographic or
angiographic evidence of a wall motion abnormality in the
corresponding area were recruited for this study between
October 12, 2016 and June 26, 2017 (Fig. 2). In order to
improve risk stratification before elective Percutaneous
Coronary Intervention (PCI) of the CTO, all patients
underwent a hybrid 18F-FDG PET-MR examination in a
Biograph mMR scanner (Siemens Healthcare, Erlangen,
Germany). Relevant patient characteristics include: age 66.1
± 9.5 years, 9 males, 5 females, LVEF 49 ± 12, and previous
PCI stenting of at least one of the coronary arteries. Written
informed consent with respect to participation was obtained
from all subjects; the study was performed in concordance
with the Declaration of Helsinki and approved by the institu-
tional ethics committee.
The clinical PET-MR examination protocol included a scan
of 40 to 50 min with a list-mode PET acquisition for the
assessment of myocardial viability under insulin-clamped
conditions 60 min after injection of 326 ± 29 MBq of 18F-
FDG, and a multi-slice 2D-Phase Sensitive Inversion
Recovery (PSIR) LGE acquisition (1.4–2.2 mm in-plane res-
olution, 8 mm slice thickness). During the 10–15 min waiting
time required for optimal contrast in LGE images, an acquisi-
tion with a prototype implementation of the proposed PET-
CMRA sequence was performed.
For the CMRA acquisition, relevant imaging parameters
included: coronal orientation, resolution = 1 × 1 × 2 mm3 (in-
terpolated to 1mm3 isotropic resolution during image recon-
struction), field of view = 304 × 304 × 88–112 mm3 covering
the whole heart, TR/TE = 3.72/1.70 ms, and flip angle = 15°.
A subject-specific trigger delay was defined targeting the mid-
diastolic quiescent period of the cardiac cycle, and an
Eligible patients:
 Symptomatic CAD, CTO,
wall motion abnormality.
October 2016 to June 2017
N = 14
Day 1:
Cardiac 18F-FDG 
PET-MR examination
Day 2:
CTO revascularization 
including X-Ray 
angiography
Motion-corrected 
simultaneous 
PET-CMRA
N = 11
Patients excluded:
- No MR contrast agent (n = 1)
- No PET-CMRA overlap (n = 2)
Fig. 2 Flow chart of patients included in the study
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acquisition window of 89 to 119 ms (corresponding to 24 to
32 lines per spiral interleaf) was selected depending on the
length of the mid-diastolic period. The 2D iNAVs were ac-
quired using the following parameters: same field of view as
the CMRA acquisition, flip-angle = 3°, 14 acquired lines with
a centric-in Cartesian trajectory, corresponding to a 1 ×
21.7 mm2 acquired resolution, interpolated to 1 × 1 mm2 be-
fore FH and RL motion estimation. The vendor-provided Fat
Sat prepulse was used, and an adiabatic T2-prep (50 ms dura-
tion) was implemented to improve tissue contrast. μ-maps
were acquired for each patient during a 19 s breath-hold at
end-expiration using the vendor’s standard Dixon protocol
(acquisition parameters: coronal orientation, resolution =
2.6 × 2.6 × 3.1 mm3, field of view = 328 × 500 × 399 mm3,
TR/TE1/TE2 = 3.60/1.23/2.46 ms). All patients underwent in-
terventional X-ray angiography the day after the PET-MR
examination, for elective CTO revascularization.
CMRA and PET datasets were reconstructed with the de-
scribed motion correction scheme (MC) and without motion
correction (NMC) for comparison purposes. For each patient,
the fraction of list-mode PET data acquired simultaneously
with the CMRA sequence was selected for PET image recon-
struction. Due to variations in planning time, the overlap be-
tween CMRA and list-mode PET acquisition varied between
patients, with an average overlap of 80.3 ± 20.9% of the du-
ration of the CMRA acquisition.
MR image reconstruction was performed offline in
MATLAB (Mathworks, Natick, Massachusetts, USA) using
custom developed software. PET image reconstruction was
performed offline using reconstruct-transform-average [13]
motion correction. For this, the standard μ-map acquired at
end-expiration was moved to each respiratory position in
MATLAB using the deformation fields estimated from MR
images. Each respiratory bin was independently reconstructed
offline with e7 Tools (Siemens Healthcare, Knoxville, USA)
using the OSEM algorithm, with three iterations and 21 sub-
sets, point spread function modelling, voxel size = 2.03 ×
2.08 × 2.08 mm3, and matrix size = 127 × 344 × 344. Finally,
images reconstructed at each respiratory position were com-
bined in MATLAB to produce a motion corrected PET image.
Image analysis
Reconstructed CMRA images were reformatted to simulta-
neously visualise the left anterior descending (LAD) artery
and right coronary artery (RCA) using dedicated software
[26]. Metrics of visible vessel length and sharpness were ob-
tained for vessels without stents in the proximal artery. Vessel
sharpness values were normalised to the signal intensity of the
centre line of each vessel, so that 100% sharpness refers to a
maximum signal intensity change at the vessel edge.
Additionally, motion corrected CMRA images were
reformatted following the anatomy observed in the X-ray an-
giography in order to compare both visually.
Reconstructed 18F-FDG PET images were analysed by au-
tomatically applying the 17-segment model according to the
American Heart Association [27] to the left ventricular myo-
cardium using dedicated software (MunichHeart [28]). The
relative increase in 18F-FDG signal of motion corrected im-
ages over uncorrected images was computed for each of the 17
segments for each patient. Additionally, NMC and MC PET
images were reoriented in short axis to visually compare them
with LGE images.
Results
Scans were successfully completed in all subjects. The av-
erage acquisition time for the proposed PET-CMRA frame-
work was 11.2 ± 2.4 min. Due to differences in planning
time, in two of the patients there was no overlap between
the PET and the CMRA acquisition, so that motion correc-
tion of the PET data could not be performed. Additionally,
one of the patients was not able to receive the gadolinium-
based contrast agent. These three patients were excluded
from the following analysis. For the rest of the patients
(N = 11), the average overlap between PET and CMRA ac-
quisition was 8.8 ± 1.2 min, corresponding to list-mode PET
data being acquired during 80.3 ± 20.9% of the duration of
the CMRA acquisition on average.
Reformatted images showing non-stented RCA and LAD
for three of the patients are shown in Fig. 3. Improvements in
the delineation of the RCA and LAD were observed in the
CMRA images after applying MC, allowing for depiction of
non-stented vessels, even in cases where severe respiratory
motion prevented the visualisation of both the left and right
proximal coronary arteries in the NMC image, as observed for
Patient 1. Figure 4 shows example coronal slices of the 18F-
FDG PET images reconstructed for three representative pa-
tients. MC increased the sharpness of the left ventricle myo-
cardium and improved visualisation of small features such as
the papillary muscles (blue arrows) and delineation of viabil-
ity defects (red arrow) compared to NMC.
A visual comparison between the reformatted MC CMRA
and the corresponding invasive X-ray angiogram is shown in
Fig. 5 for two patients. Adequate spatial resolution and con-
trast in CMRA images allowed for a depiction of the proximal
arteries comparable to the X-ray angiogram for both cases. In
Patient 6, a stenosis observed in the mid segment of the RCA
in CMRA was confirmed in the angiogram (Fig. 5, red
arrows), while in Patient 7 an aneurysm in the proximal
RCAwas seen in both modalities (Fig. 5, green arrows).
Figure 6 shows a short axis view of the 18F-FDG PET both
for NMC and MC reconstructions and corresponding slice of
the 2D LGE scan for two patients. It can be observed that MC
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Fig. 3 Reformatted images for three representative patients (columns) showing uncorrected (NMC) and motion-corrected (MC) CMRA. Improvements
in the visualisation of the vessels are observed when applying MC (green arrows) for all cases, particularly in the distal segments of the arteries
Fig. 4 Coronal slice for three representative patients (columns) showing uncorrected (NMC) andmotion-corrected (MC) viability 18F-FDG PET images.
Improvements in image quality can be observed when applying MC, particularly in small structures (blue and red arrows), compared to NMC
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Fig. 5 Reformatted CMRA and
corresponding X-ray angiogram
for two representative patients.
Red arrows: stenosis in the mid
segment of the right coronary
artery (RCA); green arrows:
aneurysm in the proximal
segment of the RCA
Fig. 6 Short axis view for two representative patients (rows) showing
uncorrected (NMC) and motion-corrected (MC) viability 18F-FDG PET
images, and corresponding 2D LGE scans. MC improves the
correspondence of the PET images to the anatomy as observed in the
LGE images, particularly in the delineation of viability defects (green
and blue arrows) and right ventricle myocardium (pink arrow)
Eur J Nucl Med Mol Imaging
PET images have an improved correspondence to the anatomy
as observed in the LGE images and reduced noise compared
to NMC images. In particular, improvements in delineation of
viability defects are apparent: for Patient 6, the transmural
viability defect observed in the infero-lateral wall was better
depicted after motion correction (Fig. 6, blue arrows), while in
Patient 8, motion correction allowed for the identification of
viable myocardium in a defect that appeared misleadingly as
transmural in the NMC image (Fig. 6, green arrows). MC also
enabled the depiction of thinner structures, such as right ven-
tricle myocardium (Fig. 6, pink arrow).
Image quality metrics for the NMC and MC CMRA im-
ages are shown in Fig. 7. Tracking of the vessels was possible
in 14 out of 15 non-stented vessels (8 RCA, 6 LAD). In one of
the patients, significant cardiac motion prevented the visuali-
sation of the coronary arteries. For the rest of the vessels,
increased visible length of the vessels were observed after
MC for both the RCA (+49.9% on average) and the LAD
(+32.6% on average) (Fig. 7a, c). Similarly, vessel sharpness
increased by 12.3% and 18.9% on average for the proximal
RCA and LAD respectively when using MC (Fig. 7b, d).
Polar maps showing the relative increase in 18F-FDG PET
signal after motion correction in the left ventricular myocar-
dium are displayed in Fig. 8 for two patients with distinct
respiratory patterns (Fig. 8a-b) and on average across the co-
hort (Fig. 8c). For the patient with significant respiratory mo-
tion (Fig. 8a), the average signal increased across all segments
was 33%, with a maximum in the anterior wall. For the patient
with moderate respiratory motion (Fig. 8b), an average of 3%
signal increase was observed across all segments. When con-
sidering the cohort averages for each myocardial segment
(Fig. 8c), signal increased most towards the inferior and
inferolateral regions, i.e. by an average of 8% across the six
corresponding sectors of the myocardium.
Figure 9 shows an example fused PET-CMRA dataset be-
fore and after motion correction. The framework produces co-
registered diagnostic PET and CMRA images, improving the
correspondence between modalities compared to uncorrected
images.
Discussion
In this study we have tested a novel approach for the simul-
taneous visualisation of coronary anatomy by CMRA and
myocardial viability by 18F-FDG PET in patients with cor-
onary artery disease. The framework incorporates 2D im-
age-navigation, and uses motion estimated fromMR to cor-
rect both the PET and CMRA datasets, producing respira-
tory motion-corrected co-registered images. In contrast to
recently proposed MR-based motion correction approaches
for cardiac PET data that utilise MR images mainly for im-
proving PET image quality [15–17], our approach produces
diagnostic images in both modalities, potentially reducing
total examination time. Furthermore, the proposed PET-
CMRA acquisition and reconstruction scheme has a short
and predictable scan time of approximately 11 min, which
makes it suitable for clinical practice. Indeed, for this study
the proposed PET-CMRA acquisition was included into a
standard clinical PET-MR protocol during the waiting time
required for conventional LGE imaging.
The motion correction framework for CMRA data has
been previously shown and validated for healthy subjects
[18, 20], but to the best of the authors’ knowledge, this is the
first study that shows the feasibility of applying such frame-
work to patients with cardiovascular disease. For the cohort
of patients in this study, improvement in image quality after
motion correction is apparent, allowing for the visualisation
Fig. 7 Image quality analysis for uncorrected (NMC) and motion-
corrected (MC) CMRA images in 11 patients, including: visible vessel
length for (a) RCA and (c) LAD, for each of the patients (green/blue
lines) and average (red line); and vessel sharpness for (b) RCA and (d)
LAD. Visible vessel length and sharpness improve after motion
correction for all cases. Image analysis was performed in vessels
without stents in the proximal segment
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of 14 out of 15 non-stented vessels and increasing visible
length and sharpness of the coronary arteries. Furthermore,
visual comparison showed good agreement between the
motion-corrected CMRA and gold standard invasive X-
ray angiograms, including visualisation of stenosis and an-
eurysm in the proximal segment of the arteries (Fig. 5).
For the 18F-FDG myocardial viability PET images, the pro-
posed motion correction approach improved the depiction of
small structures such as the right ventricle myocardium and
papillary muscles, and enhanced the visualisation of transmural
and non-transmural viability defects in the left ventricle myocar-
dium. In general, motion correction produced an increased PET
signal in each of the myocardial segments, with an average of
8% relative increase for the inferolateral wall. When analysing
the relative signal increase for each dataset, it was observed that
improvements were strongly related to the respiratory pattern of
each subject: modest increase in signal was obtained in patients
with shallow breathing, while increases of up to 33% on average
were observed in patients with significant respiratory motion.
Such increases come both from a reduction in the blurring and
Fig. 8 17-segment polar maps of the relative increase in 18F-FDG PETsignal after motion correction for the left ventricular myocardium. Representative
patients with (a) high amplitude respiratory motion and (b) moderate respiratory motion, and (c) the average across the cohort
Fig. 9 Example fused PET-CMRA image (Patient 4) showing uncorrected (NMC) and motion-corrected (MC) images. The motion correction frame-
work produces co-registered diagnostic PET and MR images where an improved correspondence between both modalities can be observed
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from appropriate alignment between attenuationmaps and emis-
sion data in the motion corrected reconstruction framework.
This is particularly significant in the anterior wall (Fig. 8a),
located closer to the heart-lung interface, which is consistent
with findings in recent studies [29]. Our results suggest that
respiratory motion compensation is fundamental for avoiding
misinterpretation of non-viable segments in the myocardium
by 18F-FDG PET. An improved correspondence to the anatomy
and delineation of transmural and non-transmural myocardial
viability defects was observed when comparing LGE-MRI with
the motion corrected PET images. Recent studies have com-
pared conventional LGE-MRI and 18F-FDG PET for the assess-
ment of myocardial viability [8, 30], finding good agreement
between the two modalities. However, both studies report some
mismatches between 18F-FDG PETand LGE. It is worth noting
that in these studies LGE-MR images were acquired during
breath-hold using 2D ECG-triggered sequences, as convention-
ally done in clinical practice, to minimise cardiac and respiratory
motion. On the contrary, in both studies, PET images did not
include any motion compensation technique, which could par-
tially explain the mismatches between the two modalities.
Further simultaneous 18F-FDG PETand LGE-MRI studies with
3D MR acquisition sequences that allow for motion compensa-
tion in both modalities (such as the recently proposed BOOST
sequence [31]) could allow for a fairer comparison.
This study has a number of limitations. First, the presence
of stents in at least one of the coronary arteries for each of the
patients limited the number ofMR visible vessels available for
analysis. A larger cohort would be required to provide a suf-
ficient number of vessels for a more robust statistical analysis
of improvements in image quality after motion correction.
Second, variations in the overlap between the CMRA and
PET acquisitions resulted in high variability in the fraction
of PET data that could be motion corrected and therefore in
the quality of the PET images. An acquisition protocol with an
extended PET list-mode acquisition that guarantees full over-
lap between the two acquisitions would allow for using the
full capabilities of the motion correction approach. Third, pa-
tients with known chronic total occlusion were recruited for
this study. In order to assess the diagnostic performance of the
proposed simultaneous visualisation of myocardial viability
and coronary anatomy a similar study would need to be per-
formed in subjects with suspected coronary artery disease.
Our PET-CMRA protocol includes the acquisition of a
Dixon-based attenuation correction map, which segments the
image into four tissue classes and assigns a fixed attenuation
value to each of them [23]. Studies have shown that assigning a
fixed attenuation value to the lung tissue can affect accuracy of
the PET images in the thoracic region, inducing bias in quanti-
fication of lung lesions [32] and volumes of interest within the
lungs [33]. However, such effect was shown to be less signifi-
cant in cardiac structures. Moreover, the study by Lau et al. [34]
showed no statistically significant difference in average
myocardial uptake when comparing PET-CT and PET-MR
using Dixon-based attenuation correction.
The proposed motion compensation technique only ad-
dresses the problem of respiratory motion. In CMRA, the
problem of cardiac motion was addressed by acquiring data
only during the quiescent mid-diastolic period of the cardiac
cycle. A similar approach could be used for the PET data by
rejecting the fraction of data that falls outside the diastolic
period, however, this would impact image quality by in-
creasing the noise in the PET images. Alternatively, if infor-
mation about cardiac motion is available, it could be includ-
ed in the PET image reconstruction process [35]. The pro-
posed approach does not include a mechanism for compen-
sating for unpredictable bulk motion of the patient during
the PET-CMRA examination. Techniques such as the one
proposed by Kolbitsch et al. [36] for detection and correc-
tion of whole-body motion in both PET and MR could be
adapted to be used with the proposed framework. Finally, in
this work, one PET image is independently reconstructed
for each respiratory position, and then transformed into the
reference end-expiratory position. This approach has been
shown to introduce bias due to the reduced number of
counts in each respiratory position in simulation studies
[37, 38]. Future work will include the deformation fields
directly in the motion compensated PET reconstruction pro-
cess by modifying the system matrix [14].
Conclusion
We have presented a first clinical validation of a novel respira-
tory motion-corrected whole-heart PET-CMRA framework for
simultaneous visualisation of coronary anatomy and myocardi-
al integrity in patients with coronary artery disease. The frame-
work allows for acquiring diagnostic images with both modal-
ities in a time efficient examination. The reported results have
shown that motion correction improves image quality for both
modalities compared to the uncorrected images. A good agree-
ment between coronary anatomy depicted by motion-corrected
CMRA and X-ray angiography was observed. In addition,
motion-corrected 18F-FDG PET images were in good agree-
ment with LGE-MRI, showing more accurate depiction of both
transmural and non-transmural viability defects.
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